Andrew J. Schwab, 10% Owner: Entrada Therapeutics TRDA Sell · Filed 25/11/18

Trade details

Type: Insider sale
Amount: $1,760,000
Shares · price: 200,000 sh · $8.80 a share
Held after: 2,963,066 sh
Stock: Entrada Therapeutics TRDA
Person: Andrew J. Schwab10% Owner
Trade date: 25/11/14
Filed: 25/11/18
Days to filing: 4 days

Sold 6.3% of holdings

Share of holding sold: 6.3%

Entrada Therapeutics trades, last 26 weeks

What else happened in Entrada Therapeutics around then

Filed or reported within 30 days of the trade day · 25/10/15~25/12/14

Andrew J. Schwab's recent trades

Andrew J. SchwabDirector
SellSkye Bioscience
Sell
Skye Bioscience
SKYE
$184.9K
114,851 sh
$184.9K
Filed 09/24
Traded 09/23
Andrew J. SchwabDirector
SellSkye Bioscience
Sell
Skye Bioscience
SKYE
$45.6K
27,612 sh
$45.6K
Filed 09/24
Traded 09/22
Andrew J. SchwabDirector
SellSkye Bioscience
Sell
Skye Bioscience
SKYE
$7,290
4,528 sh
$7,290
Filed 09/24
Traded 09/23
Andrew J. SchwabDirector
SellSkye Bioscience
Sell
Skye Bioscience
SKYE
$1,795
1,088 sh
$1,795
Filed 09/24
Traded 09/22
Andrew J. SchwabDirector
SellSkye Bioscience
Sell
Skye Bioscience
SKYE
$560.8K
163,979 sh
$560.8K
Filed 25/08/22
Traded 25/08/22